Christopher Moxham, Chief Scientific Officer at Fulcrum Therapeutics, Inc. (FULC), sold 31,071 shares at $18.00 ($559K) on 2021-08-10, disclosed to the SEC on 2021-08-12.
Open-market sale of $559k FULC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.